Clinical Trials Browser

3-Iodobenzylguanidine × Endocrine × 1 year × Clear all

NCT00107289 2026-03-13

Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

Phase 2 Recruiting

Neuroblastoma, Pheochromocytoma

NCT01850888 2025-12-18

MIBG for Refractory Neuroblastoma and Pheochromocytoma

Phase NA Completed

Neuroblastoma, Pheochromocytoma